ROYALSILK 2XLARGE, Gown. Item Code 9578

FDA Device Recall #Z-1023-2020 — Class II — January 11, 2020

Recall Summary

Recall Number Z-1023-2020
Classification Class II — Moderate risk
Date Initiated January 11, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cardinal Health
Location Waukegan, IL
Product Type Devices
Quantity 7,659,634 total units

Product Description

ROYALSILK 2XLARGE, Gown. Item Code 9578

Reason for Recall

The gowns contain an unknown level of bioburden, unknown microbiological flora, and unknown particulate contamination.

Distribution Pattern

Worldwide distribution US Nationwide including Puerto Rico and Guam, United Arab Emirates, Australia, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Israel, Mexico, Oman, Panama, Philippines, and Saudi Arabia.

Lot / Code Information

Lot Numbers: XXXXJXXX Single-Sterile Lot Format: YYMRJXXX Where: YY Last two digits of the year ( 18 or '19) M Month in alpha code " If made in 2018 o J for September o K for October o L for November OR o M for December " If made in 2019, any value is affected R Product revision or suffix P Facility code is letter J XXX Sequential Number - Monthly reset OR Bulk Non-Sterile Lot Format: XXXYRPQ Where: XXX Elapsed days of year " " If made in 2018, 244 or greater is affected OR " " If made in 2019, any value is affected; see below for year made identifier Y Last character of year gown was made (2018 or 2019) R Product Revision P Facility code is letter J Q Plant shift identifier; this identifier was added during the affected time period and therefore older product may not contain this digit in the lot number

Other Recalls from Cardinal Health

Recall # Classification Product Date
Z-0360-2023 Class II Dover Closed Urethral Tray with Vinyl Catheter ... Nov 1, 2022
Z-0359-2023 Class II Dover Closed Urethral Tray with Vinyl Catheter ... Nov 1, 2022
Z-0357-2023 Class II Dover Closed Urethral Tray with Hydrogel Coated... Nov 1, 2022
Z-0356-2023 Class II Dover Closed Urethral Tray with Vinyl Catheter ... Nov 1, 2022
Z-0358-2023 Class II Dover Closed Urethral Tray with Hydrogel Coated... Nov 1, 2022

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.